Sagimet Biosciences
SGMT
SGMT
70 hedge funds and large institutions have $44.9M invested in Sagimet Biosciences in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
+4
Holders Change %
+6.06%
% of All Funds
0.95%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
16
Reduced
18
Closed
13
Calls
$539K
Puts
$436K
Net Calls
+$103K
Net Calls Change
+$1.09M
Top Buyers
| 1 |
Raymond James Financial
St Petersburg,
Florida
|
+$1.13M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$792K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$474K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$165K |
| 5 |
DP
Diadema Partners
Morristown,
New Jersey
|
+$150K |
Top Sellers
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.29M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.83M |
| 4 |
Millennium Management
New York
|
-$1.74M |
| 5 |
6CM
683 Capital Management
New York
|
-$622K |
